Streetbeat News

WELL

Welltower Inc.

https://www.welltower.com

Industry

REIT - Healthcare Facilities

Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

Open

138.00

Mkt cap

86B

Volume

2.5M

High

140.19

P/E Ratio

88.59

52-wk high

140.19

Low

137.91

Div yield

0.02

52-wk low

84.38

Welltower (NYSE:WELL) has delivered an average annual return of 16.43% over the past 15 years, outperforming the market by 4.5% annually. A $100 investment in WELL 15 years ago would be worth $1,051.30 today. The company's current market capitalization stands at $48.99 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:30 pm

Keybanc analyst Todd Thomas has maintained an Overweight rating on Welltower (NYSE:WELL) and increased the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 10:21 am

Welltower (NYSE:WELL) has been evaluated by 8 financial analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target is $94.88, up 5.76% from the previous $89.71. Analysts from firms like Mizuho, JP Morgan, RBC Capital, Evercore ISI Group, Wells Fargo, Raymond James, and Keybanc have raised their price targets, reflecting a positive outlook. Welltower's financials show a strong market presence, solid revenue growth, but challenges in profitability and return on equity, while excelling in asset utilization and maintaining a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 6:00 pm

Mizuho analyst Omotayo Okusanya has reaffirmed a Buy rating on Welltower (NYSE:WELL) and increased the price target from $90 to $98, signaling confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:42 pm

Over the past 15 years, Welltower (NYSE:WELL) has produced an average annual return of 16.26%, outperforming the market. A $1000 investment in WELL 15 years ago would be worth $9,718.14 today. Welltower currently has a market cap of $49.80 billion.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 3:30 pm

Welltower (NYSE:WELL) has received updated ratings and price targets from 9 financial analysts in the last quarter. The average 12-month price target is $93.22, with a high of $101.00 and a low of $83.00. The ratings are mostly bullish or neutral, with 1 bullish, 4 somewhat bullish, and 4 indifferent. Notably, the average price target has increased by 3.91% over the past month. Welltower's financial health indicators show a strong market presence, positive revenue trend, but below-average net margin and ROE, with an exceptional ROA and a balanced debt approach.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 9:01 pm

Welltower (NYSE:WELL) received 9 analyst ratings in the last quarter, with an average 12-month price target of $93.22, a high of $101.00, and a low of $83.00. The current average reflects a 3.91% increase from the previous average of $89.71. Analysts from firms like JP Morgan, RBC Capital, and Raymond James have raised their price targets, indicating a positive sentiment towards Welltower's stock. The company has shown a positive revenue trend with a growth rate of 12.77% as of September 30, 2023, but has a net margin and ROE below industry averages, although its ROA and debt management are strong.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:39 pm

JP Morgan analyst Michael Mueller has upgraded Welltower (NYSE:WELL) from Neutral to Overweight and increased the price target from $92 to $99.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 10:21 am

Welltower (NYSE:WELL) has seen a 14.29% decrease in short interest since its last report, with 7.07 million shares sold short, representing 1.86% of its float. The average time to cover these short positions is 2.66 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Welltower's short interest is below its peer group average of 5.88%. Short interest levels can be a market sentiment indicator, and changes in short interest can impact stock price movements.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 2:45 pm

Welltower Inc. (NYSE:WELL) stock price dropped by 0.26% to $88.37 in the current market session, despite a 3.29% increase over the past month and a 32.78% rise over the past year. The article discusses the P/E ratio of Welltower in comparison to its industry peers, noting that Welltower's P/E is lower than the Health Care REITs industry average of 275.71. This could indicate that Welltower's stock is undervalued or that investors have lower growth expectations for the company. The P/E ratio, while useful, should not be the sole metric for investment decisions and should be used alongside other financial metrics and qualitative analysis.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 3:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.